BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 28396115)

  • 1. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.
    Berhane AM; Weil EJ; Knowler WC; Nelson RG; Hanson RL
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
    Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
    Krolewski AS; Skupien J; Rossing P; Warram JH
    Kidney Int; 2017 Jun; 91(6):1300-1311. PubMed ID: 28366227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.
    Bhensdadia NM; Hunt KJ; Lopes-Virella MF; Michael Tucker J; Mataria MR; Alge JL; Neely BA; Janech MG; Arthur JM;
    Kidney Int; 2013 Jun; 83(6):1136-43. PubMed ID: 23536133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
    Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?
    Weldegiorgis M; de Zeeuw D; Dwyer JP; Mol P; Heerspink HJL
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1595-1600. PubMed ID: 28923834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.
    Skupien J; Warram JH; Smiles AM; Niewczas MA; Gohda T; Pezzolesi MG; Cantarovich D; Stanton R; Krolewski AS
    Kidney Int; 2012 Sep; 82(5):589-97. PubMed ID: 22622493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical update: The important role of dual kidney function testing (ACR and eGFR) in primary care: Identification of risk and management in type 2 diabetes.
    Seidu S; Barrat J; Khunti K
    Prim Care Diabetes; 2020 Aug; 14(4):370-375. PubMed ID: 32139245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
    Panduru NM; Saraheimo M; Forsblom C; Thorn LM; Gordin D; Wadén J; Tolonen N; Bierhaus A; Humpert PM; Groop PH;
    Diabetes Care; 2015 May; 38(5):883-90. PubMed ID: 25720601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Oellgaard J; Gæde P; Rossing P; Persson F; Parving HH; Pedersen O
    Kidney Int; 2017 Apr; 91(4):982-988. PubMed ID: 28187983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L; Huang L; Wu H; Lou Q; Bian R
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease.
    Kim SJ; Smail N; Paraskevas S; Schiff J; Cantarovich M
    Transplantation; 2014 Mar; 97(6):675-80. PubMed ID: 24637866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.